Literature DB >> 2702892

Amyloidosis mimics achalasia's effect on lower esophageal sphincter.

J R Lefkowitz1, D L Brand, M D Schuffler, W R Brugge.   

Abstract

Esophageal involvement in systemic amyloidosis is common. Manometric studies have been few in number and have revealed a variety of findings compatible with deposition of amyloid in myopathic as well as neuropathic patterns. This report describes a patient with primary amyloid whose esophageal dysfunction was limited to the lower esophageal sphincter, with both a hypertensive sphincter and impaired relaxation after swallows. Pharmacologic testing confirmed a mild abnormality of the inhibitory pathway to the LES with an intact excitatory pathway and sphincter muscle. This case suggests that amyloidosis, like idiopathic achalasia and carcinoma of the lower esophagus, can produce dysphagia by selective impairment of the inhibitory neural pathway to the lower esophageal sphincter.

Entities:  

Mesh:

Year:  1989        PMID: 2702892     DOI: 10.1007/BF01536343

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  ACHALASIA OF THE ESOPHAGUS: PATHOLOGIC AND ETIOLOGIC CONSIDERATIONS.

Authors:  R R CASSELLA; A L BROWN; G P SAYRE; F H ELLIS
Journal:  Ann Surg       Date:  1964-09       Impact factor: 12.969

2.  Primary systemic amyloidosis.

Authors:  H N EISEN
Journal:  Am J Med       Date:  1946-08       Impact factor: 4.965

3.  Deposition of amyloid in the gastrointestinal tract.

Authors:  T Gilat; M Revach; E Sohar
Journal:  Gut       Date:  1969-02       Impact factor: 23.059

4.  Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia.

Authors:  W J Dodds; J Dent; W J Hogan; G K Patel; J Toouli; R C Arndorfer
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

5.  Esophageal manometry in familial amyloid polyneuropathy.

Authors:  R Burakoff; A Rubinow; A S Cohen
Journal:  Am J Med       Date:  1985-07       Impact factor: 4.965

6.  Effect of metoclopramide on oesophageal peristalsis and gastro-oesophageal sphincter pressure. A study in normal subjects.

Authors:  L Wallin; S Boesby; T Madsen
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

7.  Action of oral metoclopramide on the gastrooesophageal junction in man.

Authors:  J B Dilawari; J J Misiewicz
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

8.  Achalasia of the cardia: pharmacology and histopathology of isolated cardiac sphincteric muscle from patients with and without achalasia.

Authors:  J J Misiewicz; S L Waller; P P Anthony; J W Gummer
Journal:  Q J Med       Date:  1969-01

9.  Metoclopramide in gastrooesophageal reflux.

Authors:  C Stanciu; J R Bennett
Journal:  Gut       Date:  1973-04       Impact factor: 23.059

Review 10.  Metoclopramide: pharmacology and clinical application.

Authors:  R Albibi; R W McCallum
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

View more
  4 in total

1.  Tough to Swallow: Esophageal Food Impaction from Esophageal Amyloidosis.

Authors:  Sonali Palchaudhuri; Toby Cornish; Casey Inouye; Ashish Nimgaonkar
Journal:  Dig Dis Sci       Date:  2017-05       Impact factor: 3.199

Review 2.  Pathophysiology of achalasia.

Authors:  I Hirano
Journal:  Curr Gastroenterol Rep       Date:  1999-06

3.  Reversible achalasia-like motor pattern of esophageal body secondary to postoperative stricture of gastroesophageal junction.

Authors:  P Parrilla; J L Aguayo; L Martinez de Haro; A Ortiz; D A Martinez; G Morales
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

4.  Breath hydrogen test using water-diluted lactulose in patients with gastrointestinal amyloidosis.

Authors:  T Matsumoto; M Iida; M Hirakawa; K Hirakawa; F Kuroki; S Lee; T Nanbu; M Fujishima
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.